J&J/Kodak
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson completes its $1 bil. acquisition of Kodak's Clinical Diagnostics Division on Nov. 30. The deal, announced Sept. 6 ("The Gray Sheet" Sept. 12, p. 1), includes the transfer of "all personnel, patents, technology, production equipment, products and inventories," J&J says